All BioLAGO projects reflect the most important trends in the healthcare industry, above all digitalisation and artificial intelligence. In the AIQNET project, which was funded by the German Federal Ministry of Economics and Technology, BioLAGO worked with 15 partners, including Charité Berlin and Aesculap, to provide patients with the best possible therapies and to further improve medical technology products.
The aim of the project was to facilitate the implementation of the stricter EU regulations on the safety of medical technology products through digital tools. Artificial intelligence was used as a key technology. Medical data is to be made exchangeable and thus usable for research, diagnosis and treatment. In the project, a digital platform was being created that will enable users to use data-based applications in the health sector for their own purposes or to accelerate the development of new business areas and services. In this way, value creation is increased and vital medical technology products remain available. At the same time, AIQNET improves the individual treatment of patients, for example by identifying risk factors before surgery. This allows doctors to act in preparation instead of having to react to a complication.
The project developed a digital ecosystem that integrates the analysis of treatment processes with artificial intelligence into everyday clinical practice and that will be available to all medical technology experts worldwide. BioRegio STERN Management GmbH coordinated the project for the 16 funded partners and more than 40 associated partners. Innovative solutions were developed that use artificial intelligence to enable the rapid collection and storage of clinical data.
What is unique about the project is that, in addition to medical technology companies, clinics can also benefit significantly. This is because all stakeholders are taken into account in the growing ecosystem, whether they are providers of applications or manufacturers of medical devices. Together, new strategies and business models can be developed to further advance the digitalisation of healthcare.
Further information HERE